Yoshizato Project, Cooperative Link of Unique Science and Technology for Economy Revitalization, Hiroshima Prefectural Institute of Industrial Science and Technology, Hiroshima, Japan.
Am J Pathol. 2010 Aug;177(2):654-65. doi: 10.2353/ajpath.2010.090430. Epub 2010 Jun 3.
Liver mass is optimized in relation to body mass. Rat (r) and human (h) hepatocytes were transplanted into liver-injured immunodeficient mice and allowed to proliferate for 3 or 11 weeks, respectively, when the transplants stopped proliferating. Liver/body weight ratio was normal throughout in r-hepatocyte-bearing mice (r-hep-mice), but increased continuously in h-hepatocyte-bearing mice (h-hep-mice), until reaching approximately three times the normal m-liver size, which was considered to be hyperplasia of h-hepatocytes because there were no significant differences in cell size among host (mouse [m-]) and donor (r- and h-) hepatocytes. Transforming growth factor-beta (TGF-beta) type I receptor, TGF-beta type II receptor, and activin A type IIA receptor mRNAs in proliferating r-hepatocytes of r-hep-mice were lower than in resting r-hepatocytes (normal levels) and increased to normal levels during the termination phase. Concomitantly, m-hepatic stellate cells began to express TGF-beta proteins. In stark contrast, TGF-beta type II receptor and activin A type IIA receptor mRNAs in h-hepatocytes remained low throughout and m-hepatic stellate cells did not express TGF-beta in h-hep-mice. As expected, Smad2 and 3 translocated into nuclei in r-hep-mice but not in h-hep-mice. Histological analysis showed a paucity of m-stellate cells in h-hepatocyte colonies of h-hep-mouse liver. We conclude that m-stellate cells are able to normally interact with concordant r-hepatocytes but not with discordant h-hepatocytes, which seems to be at least partly responsible for the failure of the liver size optimization in h-hep-mice.
肝脏质量与体重相关。将大鼠(r)和人(h)肝细胞分别移植到肝损伤免疫缺陷小鼠体内,并分别允许其增殖 3 或 11 周,此时移植停止增殖。r-肝细胞移植小鼠(r-hep-小鼠)的肝/体重比在整个过程中均正常,但在 h-肝细胞移植小鼠(h-hep-小鼠)中持续增加,直至达到正常 m-肝大小的约三倍,这被认为是 h-肝细胞的增生,因为在宿主(鼠 [m-])和供体(r-和 h-)肝细胞之间细胞大小没有显著差异。增殖的 r-hep-小鼠中的 r-肝细胞中的转化生长因子-β(TGF-β)I 型受体、TGF-β II 型受体和激活素 A IIA 型受体 mRNA 低于静止的 r-肝细胞(正常水平),并在终止阶段增加到正常水平。同时,m-肝星状细胞开始表达 TGF-β 蛋白。与此形成鲜明对比的是,h-肝细胞中的 TGF-β II 型受体和激活素 A IIA 型受体 mRNA 始终较低,h-hep-小鼠中的 m-肝星状细胞不表达 TGF-β。正如预期的那样,Smad2 和 3 在 r-hep-小鼠中转录入核,但不在 h-hep-小鼠中转录入核。组织学分析显示 h-hep-小鼠肝中 h-肝细胞集落中 m-星状细胞稀少。我们得出结论,m-星状细胞能够与一致的 r-肝细胞正常相互作用,但不能与不一致的 h-肝细胞相互作用,这似乎至少部分是导致 h-hep-小鼠肝脏大小优化失败的原因。